Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new opportunities to expand access to their medicines through PAPs.

BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million ...

Former head of the Covid Vaccine Task Force Dr Clive Dix accused ministers of a 'fatuous argument', claiming the country is ...

Budget 2025: Seeks to further amend notification No. 16/2017-Customs, dated the 20th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified ...

The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

Metro Mayor Steve Rotheram has said he is hoping to restart talks with AstraZeneca after it scrapped plans to invest £450m in ...

Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of ...

In July last year, after the Lok Sabha elections, the Health Ministry was allocated Rs 90958.63 crore in the Union Budget 2024-25.

Cancer patients to receive relief on imported medicines through Basic Customs Duty exemptions and patient assistance programmes.

The Union Budget 2025 has allocated Rs 98,311 crore for healthcare, marking a modest increase from Rs 90,959 crore in FY24. This budget prioritizes medical infrastructure, health insurance, and ...

The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, ...